Evrogen
Private Company
Funding information not available
Overview
Evrogen is a private, revenue-generating biotechnology tools company based in Moscow, Russia. It operates as a platform and services business, providing research products such as advanced fluorescent proteins (e.g., FusionRed, TurboFP650) and ready-to-use expression vectors, alongside molecular biology services like DSN-normalization and cDNA synthesis. The company targets academic and industrial research labs worldwide, leveraging proprietary technologies to enable advanced cellular and molecular studies, though its geographic location and the niche nature of its tools present specific market and operational risks.
Technology Platform
Proprietary fluorescent protein engineering (e.g., FusionRed, Katushka2S) and Duplex-Specific Nuclease (DSN) technology for cDNA normalization and nucleic acid manipulation, combined with specialized expression vectors for subcellular labeling.
Opportunities
Risk Factors
Competitive Landscape
Evrogen competes in the crowded life science research tools market against giants like Thermo Fisher, Merck, and Takara Bio, as well as specialized fluorescent protein developers like Allele Biotechnology. It differentiates through proprietary, high-performance variants like FusionRed and its unique DSN-normalization service, carving out a niche among researchers requiring optimized reagents for specific, demanding applications.